- Motley Fool•12 hours ago
Impressive growth could be in store for biotech stocks Celgene, Ionis, and Vertex.
- American City Business Journals•2 days ago
Vertex Pharmaceuticals CEO Jeffrey Leiden is among a group of pharmaceutical executives that have reportedly been invited to meet with top officials from the Trump Administration next month to discuss issues facing the industry — a sign of the Boston drugmaker’s growing clout. The planned May 8 meeting at the White House was reported by Bloomberg News on Friday afternoon . A spokesperson for Vertex (VRTX), one of the largest drug companies based in Massachusetts, confirmed that Leiden has been invited to the summit, but declined to say whether he will attend.
- American City Business Journals•5 days ago
Two religious organizations that own shares of Vertex Pharmaceuticals are pushing the Boston drugmaker to disclose more information about its lobbying on drug pricing and other hot-button issues, an effort that the company opposes. Vertex (VRTX) said in a federal filing Monday that it will ask shareholders to reject the measure during its annual meeting in June. The measure would require Vertex to disclose how much it spends on lobbying at the local, state and federal levels, including payments it makes to trade groups and spending on “grassroots” communications that seek to shape public opinion on policy issues.
VRTX : Summary for Vertex Pharmaceuticals Incorpor - Yahoo Finance
Vertex Pharmaceuticals Incorpor (VRTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||72.00 x 100|
|Ask||116.75 x 100|
|Day's Range||115.92 - 117.69|
|52 Week Range||71.46 - 117.99|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-253.70|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|